Literature DB >> 29378755

The Cardiac Troponin Renal Disease Diagnostic Conundrum: Past, Present, and Future.

Christopher deFilippi1, Stephen Seliger2.   

Abstract

Keywords:  Editorials; chest pain; myocardial infarction; renal insufficiency; troponin

Mesh：

Substances：

Year:  2018        PMID： 29378755     DOI： 10.1161/CIRCULATIONAHA.117.031717

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Cardiac Troponin T: The Impact of Posttranslational Modifications on Analytical Immunoreactivity in Blood up to the Excretion in Urine.

Authors:  Douwe de Boer; Alexander S Streng; William P T M van Doorn; Wim H M Vroemen; Otto Bekers; Will K W H Wodzig; Alma M A Mingels
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Multi-Site Coronary Vein Sampling Study on Cardiac Troponin T Degradation in Non-ST-Segment-Elevation Myocardial Infarction: Toward a More Specific Cardiac Troponin T Assay.

Authors:  Sander A J Damen; Wim H M Vroemen; Marc A Brouwer; Stephanie T P Mezger; Harry Suryapranata; Niels van Royen; Otto Bekers; Steven J R Meex; Will K W H Wodzig; Freek W A Verheugt; Douwe de Boer; G Etienne Cramer; Alma M A Mingels
Journal:  J Am Heart Assoc       Date:  2019-07-04       Impact factor: 5.501

Review 3.  Systems analysis of miRNA biomarkers to inform drug safety.

Authors:  Amy L Schofield; Joseph P Brown; Jack Brown; Ania Wilczynska; Catherine Bell; Warren E Glaab; Matthias Hackl; Lawrence Howell; Stephen Lee; James W Dear; Mika Remes; Paul Reeves; Eunice Zhang; Jens Allmer; Alan Norris; Francesco Falciani; Louise Y Takeshita; Shiva Seyed Forootan; Robert Sutton; B Kevin Park; Chris Goldring
Journal:  Arch Toxicol       Date:  2021-09-12       Impact factor: 5.153

4.  High-Sensitivitycardiac Troponinsin Cardio-Healthy Subjects: A Cardiovascular Magnetic Resonance Imaging Study.

Authors:  Tar-Choon Aw; Wei-Ting Huang; Thu-Thao Le; Chee-Jian Pua; Briana Ang; Soon-Kieng Phua; Khung-Keong Yeo; Stuart A Cook; Calvin W L Chin
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

5.  The LIFT trial: study protocol for a double-blind, randomised, placebo-controlled trial of K+-binder Lokelma for maximisation of RAAS inhibition in CKD patients with heart failure.

Authors:  Daniel Murphy; Irina Chis Ster; Juan-Carlos Kaski; Lisa Anderson; Debasish Banerjee
Journal:  BMC Nephrol       Date:  2021-07-06       Impact factor: 2.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.